Indications and uses
for the treatment of acne
for the treatment of acne
Clean the skin thoroughly before applying this product. Cover the entire afffected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor If bothersome dryness or peeling occurs, reduce application to once a day or every other day. If going outside, ap...
Store at 20 o C - 25 o C (68 o F - 77 o F)
Benzoyl peroxide 10.0%
Acne Medication
for the treatment of acne
For external use only
If swallowed, get medical help or contact a Poison Control Center right away.
Store at 20 oC - 25 oC (68 oF - 77 oF)
carbomer, disodium EDTA, hydroxypropyl methylcellulose, laureth-4, sodium hydroxide, tocopheryl acetate, water.
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0363-1363 | 0363-1363-16, 0363-1363-17 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| HYDROXYPROPYL METHYLCELLULOSE | 3NXW29V3WO | IACT |
| LAURETH-4 | 6HQ855798J | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| .ALPHA.-TOCOPHEROL ACETATE, DL- | WR1WPI7EW8 | IACT |
| WATER | 059QF0KO0R | IACT |
| BENZOYL PEROXIDE | W9WZN9A0GM | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Maximum Strength Acne Treatment | BENZOYL PEROXIDE | WALGREEN COMPANY | 548e327b-1a4f-03df-e063-6294a90a3932 | 2026-06-18 | Warnings | 0363-1363-16 0363-1363-17 0363-1363 00363136317 00363136316 548e2621-eb31-f1c5-e063-6294a90a2844 548e327b-1a4f-03df-e063-6294a90a3932 |
Adverse event summaries are temporarily unavailable. Other product information remains available.